CROS NT understands medical device and diagnostic (MD&D) trials uniquely differ to those of the drug development industry. Differences in regulatory approval process, regulatory guidelines and the budget available to conduct essential clinical trials, requires a different approach.

MD&D companies have partnered with CROS NT to design, manage and report numerous clinical trials; taking advantage of their cost effective, device focused and unique understanding of the device development process. Dedicated to the provision of cost effective, fixed fee clinical trials, CROS NT helps customers to accurately plan and budget their clinical trials.

CROS NT has a rich history in providing consultancy services to MD&D companies to reduce trial costs, improve team efficiency and overall compliancy to ICH GCP, CFR 812, 820 and 21 CFR Part 11 compliancy.